Active ingredient: Ublituximab; ATC code: L04AG14; Pharmaceutical form: All; Strength: All; Pack size: All (excluding hospital packs)

… declarations, which can be requested from the designated contact point. The purpose of this notice is to conclude drug rebate agreements pursuant to Section 130a(8) or Section 130c(1) of the German Social Code (SGB V) on the active substance(s) referred to in Title 1. It does not concern the award of public contracts within the meaning of Directive 2014/24/EU or §§ 97 et seq. GWB. Any pharmaceutical entrepreneur may become a contractual partner in accordance with Section 4(18) AMG. According to the case law of the ECJ, such admission procedures are not necessarily subject to public procurement law, as there is no competition due to the lack of a selection decision. The notice serves as an invitation to conclude discount agreements with terms and conditions that are identical and non-dispositive for all contractual partners, including the determination of the discount. The contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the designated contact point. The purpose of this notice is to conclude drug rebate agreements pursuant to Section 130a(8) or Section 130c(1) of the German Social Code (SGB V) on the active substance(s) referred to in Title 1. It does not concern the award of public contracts within the meaning of Directive 2014/24/EU or §§ 97 et seq. GWB. Any pharmaceutical entrepreneur may become a contractual partner in accordance with Section 4(18) AMG. According to the case law of the ECJ, such admission procedures are not necessarily subject to public procurement law, as there is no competition due to the lack of a selection decision. The notice serves as an invitation to conclude discount agreements with terms and conditions that are identical and non-dispositive for all contractual partners, including the determination of the discount. The contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the designated contact point. The purpose of this notice is to conclude drug rebate agreements pursuant to Section 130a(8) or Section 130c(1) of the German Social Code (SGB V) on the active substance(s) referred to in Title 1. It does not concern the award of public contracts within the meaning of Directive 2014/24/EU or §§ 97 et seq. GWB. Any pharmaceutical entrepreneur may become a contractual partner in accordance with Section 4(18) AMG. According to the case law of the ECJ, such admission procedures are not necessarily subject to public procurement law, as there is no competition due to the lack of a selection decision. The notice serves as an invitation to conclude discount agreements with terms and conditions that are identical and non-dispositive for all contractual partners, including the determination of the discount. The contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the designated contact point. The purpose of this notice is to conclude drug rebate agreements pursuant to Section 130a(8) or Section 130c(1) of the German Social Code (SGB V) on the active substance(s) referred to in Title 1. It is not a matter of public procurement in the